Grants and Contributions:
Title:
509585
Agreement Number:
509585
Agreement Value:
$965,000.00
Agreement Date:
Nov 1, 2011 - Dec 31, 2013
Description:
Trillium Therapeutics is a biotechnology company specializing in innovative therapies of immunology and ctyoprotection. Funds will help commercialize a therapeutic treatment for interstitial cystitis.
Organization:
Innovation, Science and Economic Development Canada
Location:
Mississauga, Ontario, CA M9W4Y9
Reference Number:
033-2011-2012-Q4-509585
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
892854894
Recipient Type:
For-profit organization
Recipient's Operating Name:
Trillium Therapeutics Inc.
Recipient's Legal Name:
Trillium Therapeutics Inc.
Federal Riding Name:
Etobicoke North
Federal Riding Number:
35029
Program:
Federal Economic Development Department for Ontario
NAICS Code:
541710